share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Coen Steven P.

Ginkgo Bioworks | 4:持股变动声明-高管 Coen Steven P.

SEC announcement ·  03/08 17:03
Moomoo AI 已提取核心信息
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), was involved in a transaction on March 7, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The relationship of Coen to the issuer was noted as 'See remarks,' suggesting a need to refer to additional documentation for clarification.
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), was involved in a transaction on March 7, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The relationship of Coen to the issuer was noted as 'See remarks,' suggesting a need to refer to additional documentation for clarification.
与银杏生物工程控股有限公司(交易代码DNA.US)相关的史蒂芬·科恩于2024年3月7日参与了一笔交易。公告中未披露交易的具体细节,包括行动类型、状态、股份数量、股票性质、交易价格和交易后的持股。科恩与发行人的关系被认为是 “见备注”,这表明需要参考其他文件进行澄清。
与银杏生物工程控股有限公司(交易代码DNA.US)相关的史蒂芬·科恩于2024年3月7日参与了一笔交易。公告中未披露交易的具体细节,包括行动类型、状态、股份数量、股票性质、交易价格和交易后的持股。科恩与发行人的关系被认为是 “见备注”,这表明需要参考其他文件进行澄清。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息